Answers are grounded in this paper and cite their sources.
A ligand binding to its transmembrane receptor can activate several different signaling pathways that indirectly switch on the transcription of target genes in the nucleus. As [Heldin and Ericsson][1] explain in their Perspective, new findings reveal that some receptors such as ErbB-4 can also take a more direct approach to activating gene transcription ([ Ni et al .][2]). Once bound to ligand, ErbB-4 is proteolytically cleaved twice. First the ectodomain is released, then intramembrane cleavage releases a cytoplasmic fragment, which moves to the nucleus where it may affect gene expression. [1]: http://www.sciencemag.org/cgi/content/full/294/5549/2111 [2]: http://www.sciencemag.org/cgi/content/short/294/5549/2179
No takes yet. Share an insight, caveat, or question.
Heldin et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: